Imad Ajjawi

Imad Ajjawi, PhD, MBA, is a seasoned entrepreneur and executive with extensive experience in the biotechnology and pharmaceutical industries. Currently serving as Co-Founder and CEO of RyboDyn Inc. since June 2024, Imad focuses on developing new immunotherapies targeting the dark proteome. Previously, from January 2021 to April 2024, Imad was the VP of Business Development at Absci, where responsibilities included driving business growth and forming strategic partnerships. As Co-Founder and Chief Business Officer of Denovium Inc., acquired by Absci, Imad pioneered AI methods to enhance biopharma innovation. Imad also co-founded Glöbier, known for launching the world's first glow-in-the-dark beer. Other notable roles include Senior Business Development Manager at Synthetic Genomics, Market Analyst Consultant at Locana, and Technology Innovation Consultant at Scripps Institution of Oceanography. Imad's academic credentials include a PhD in Biochemistry from the University of Nevada, Reno, and an MBA from the Rady School of Management at UC San Diego.